Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

The S&P 500 is up 69% since bottoming in 2022, but the stocks of some industry-leading companies are still trading in the bargain bin ... yet their share prices have yet to recover and remain ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Alibaba is the leader in a $1.7 trillion market ... but the stocks of some industry-leading companies are still trading in the bargain bin. The following companies were flying high along with ...

SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards ...

Here are two stocks that are trading at cheap price-to-earnings ratios now, but that could soar over the next few years. Alibaba (NYSE: BABA) has dominant positions in China's e-commerce and cloud ...

Alibaba has scored a prized deal as it tries to carve out a lead in the highly competitive artificial intelligence race.

Alibaba will partner with Apple to support iPhones' AI services offering in China, its chairman said on Thursday, a move ...

This creates synergies with its online retail business. For example, Alibaba can use AI for product recommendations, price adjustments, and automation in delivery facilities. The e-commerce giant ...

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...

Automakers generally agree to buy parts from suppliers at fixed prices, but parts makers can’t absorb 25% ... In other cases, ...